Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shun Lu

Showing results (461-470 of 661) with videos related to

Pageof 67
Sort By:
Lung Cancer (Amsterdam, Netherlands)|August 2, 2014
Efficacy and safety of pemetrexed/cisplatin versus gemcitabine/cisplatin as first-line treatment in Chinese patients with advanced nonsquamous non-small cell lung cancerYi-Long Wu, Shun Lu, Ying Cheng, et al.
Journal of Clinical and Translational Hepatology|July 5, 2021
Icaritin Attenuates Lipid Accumulation by Increasing Energy Expenditure and Autophagy Regulated by Phosphorylating AMPKYue Wu, Ying Yang, Fang Li, et al.
Science Translational Medicine|June 18, 2025
OX40-heparan sulfate binding facilitates CAR T cell penetration into solid tumors in miceHuihui Zhang, Runbo Zhong, Wanting Wang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 10, 2021
Pyrotinib in Patients with HER2-Amplified Advanced Non-Small Cell Lung Cancer: A Prospective, Multicenter, Single-Arm TrialZhengbo Song, Dongqing Lv, Shi-Qing Chen, et al.
BJOG : an International Journal of Obstetrics and Gynaecology|November 4, 2022
Clinical outcomes of conventional HDR intracavitary brachytherapy combined with complementary applicator-guided intensity modulated radiotherapy boost in patients with bulky cervical tumourShun Lu, Shubin Wang, Robert Y Kim, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|September 22, 2023
Engineered mesenchymal stem cell-derived extracellular vesicles constitute a versatile platform for targeted drug deliveryWanrong Meng, Linlin Wang, Xueyu Du, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 12, 2017
Genome-wide DNA Methylation Analysis Reveals <i>GABBR2</i> as a Novel Epigenetic Target for <i>EGFR</i> 19 Deletion Lung Adenocarcinoma with Induction Erlotinib TreatmentXiaomin Niu, Fatao Liu, Yi Zhou, et al.
Scientific Reports|December 8, 2025
Heterogeneity of active mast cells, endothelial cells, and fibroblasts in hemophilic arthritis defined by synovial single-cell sequencingKun Lin, Shuai Fan, Xiaoqiang Yang, et al.
The Lancet. Oncology|April 20, 2012
Gefitinib versus placebo as maintenance therapy in patients with locally advanced or metastatic non-small-cell lung cancer (INFORM; C-TONG 0804): a multicentre, double-blind randomised phase 3 trialLi Zhang, Shenglin Ma, Xiangqun Song, et al.
Ying Yong Sheng Tai Xue Bao = the Journal of Applied Ecology|May 26, 2023
Altitudinal variations and seasonal dynamics of near-surface and soil temperatures in subtropical forests of Mt. Guanshan, Jiangxi Province, ChinaFang Wang, Yao-Shun Lu, Zhao-Chen Zhang, et al.
Pageof 67

Showing results (461-470 of 661) with videos related to

Sort By:
Pageof 67
Lung Cancer (Amsterdam, Netherlands)|August 2, 2014
Efficacy and safety of pemetrexed/cisplatin versus gemcitabine/cisplatin as first-line treatment in Chinese patients with advanced nonsquamous non-small cell lung cancerYi-Long Wu, Shun Lu, Ying Cheng, et al.
Journal of Clinical and Translational Hepatology|July 5, 2021
Icaritin Attenuates Lipid Accumulation by Increasing Energy Expenditure and Autophagy Regulated by Phosphorylating AMPKYue Wu, Ying Yang, Fang Li, et al.
Science Translational Medicine|June 18, 2025
OX40-heparan sulfate binding facilitates CAR T cell penetration into solid tumors in miceHuihui Zhang, Runbo Zhong, Wanting Wang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 10, 2021
Pyrotinib in Patients with HER2-Amplified Advanced Non-Small Cell Lung Cancer: A Prospective, Multicenter, Single-Arm TrialZhengbo Song, Dongqing Lv, Shi-Qing Chen, et al.
BJOG : an International Journal of Obstetrics and Gynaecology|November 4, 2022
Clinical outcomes of conventional HDR intracavitary brachytherapy combined with complementary applicator-guided intensity modulated radiotherapy boost in patients with bulky cervical tumourShun Lu, Shubin Wang, Robert Y Kim, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|September 22, 2023
Engineered mesenchymal stem cell-derived extracellular vesicles constitute a versatile platform for targeted drug deliveryWanrong Meng, Linlin Wang, Xueyu Du, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 12, 2017
Genome-wide DNA Methylation Analysis Reveals <i>GABBR2</i> as a Novel Epigenetic Target for <i>EGFR</i> 19 Deletion Lung Adenocarcinoma with Induction Erlotinib TreatmentXiaomin Niu, Fatao Liu, Yi Zhou, et al.
Scientific Reports|December 8, 2025
Heterogeneity of active mast cells, endothelial cells, and fibroblasts in hemophilic arthritis defined by synovial single-cell sequencingKun Lin, Shuai Fan, Xiaoqiang Yang, et al.
The Lancet. Oncology|April 20, 2012
Gefitinib versus placebo as maintenance therapy in patients with locally advanced or metastatic non-small-cell lung cancer (INFORM; C-TONG 0804): a multicentre, double-blind randomised phase 3 trialLi Zhang, Shenglin Ma, Xiangqun Song, et al.
Ying Yong Sheng Tai Xue Bao = the Journal of Applied Ecology|May 26, 2023
Altitudinal variations and seasonal dynamics of near-surface and soil temperatures in subtropical forests of Mt. Guanshan, Jiangxi Province, ChinaFang Wang, Yao-Shun Lu, Zhao-Chen Zhang, et al.
Pageof 67